Adipositas: Medikament reduziert bis zu 20 Prozent Körperfett heilpraxisnet.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heilpraxisnet.de Daily Mail and Mail on Sunday newspapers.
E-Mail
SILVER SPRING, Md. A new study confirms that treatment with Bimagrumab, an antibody that blocks activin type II receptors and stimulates skeletal muscle growth, is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and type 2 diabetes. These exciting results suggest that there may be a novel mechanism for achieving weight loss with a profound loss of body fat and an increase in lean mass, along with other metabolic benefits, said Steve Heymsfield, MD, FTOS, past president of The Obesity Society and corresponding author of the study. Heymsfield is professor and director of the Metabolism and Body Composition Laboratory at the Pennington Biomedical Research Center in Baton Rouge, La.
Drôme et Ardèche S amuser et se détendre pendant les vacances de Noël #3 ledauphine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ledauphine.com Daily Mail and Mail on Sunday newspapers.